Home / Market News / $ENTR

$ENTR news and market catalysts

The 1 most recent market catalysts affecting $ENTR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 0 high impact 1 bullish 0 bearish Biotechnology
Oct 14, 2026 Corporate Catalyst Bullish Impact 75
Entrada Therapeutics Reports 0.10% Mean Dystrophin Increase In 5 mg/kg Cohort Of Phase 1/2 Duchenne Trial Of ENTR-601-45; Primary Safety Goal Met
This headline represents a significant corporate catalyst for Entrada Therapeutics. Positive Phase 1/2 trial results, especially meeting the primary safety endpoint and demonstrati…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.